Fulvestrant (ICI 182780)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Fulvestrant (ICI 182780), covering 2012-07-19 to 2012-07-19. Get the full timeline:
Most recent: Clinical Trial Update: ICI 182780 in Treating Women With Stage I or Stage II Primary Breast Cancer [Phase 3]